Neurocrine Biosciences | سهم



Stock تغيير تاريخ
AbbVie USD 4.18B 269M 2024-12
Acadia Pharmaceuticals USD 22.95M 999K 2025-03
Agios Pharmaceuticals USD 27.62M 1.19M 2024-12
ALKERMES USD 182.89M 8.2M 2024-12
Alnylam Pharmaceuticals USD 65.58M 12.93M 2025-03
Amgen USD 7B 364M 2024-12
Biogen USD 2.27B 186.6M 2025-03
BioMarin Pharmaceutical USD 1.23B 53.31M 2024-12
Cytokinetics 0 0 2023-12
Dynavax Technologies USD 74.4M 4.35M 2025-03
Exelixis USD 24.85M 2.46M 2025-03
Gilead Sciences USD 3.59B 154M 2024-12
Halozyme Therapeutics USD 141.86M 10.45M 2024-12
Incyte USD 63.97M 5.1M 2025-03
Ionis Pharmaceuticals USD 11.5M 1.01M 2025-03
Neurocrine Biosciences USD 57.4M 11.6M 2024-12
Pfizer USD 10.85B 870M 2024-12
Regeneron Pharmaceuticals USD 3.97B 879M 2025-03
Repligen USD 153.11M 10.15M 2025-03
Sarepta Therapeutics USD 749.96M 184.04M 2024-12
Teva Pharmaceutical Industries USD 3.01B 952M 2024-12
Ultragenyx Pharmaceutical USD 45.01M 1.67M 2024-12
Vertex Pharmaceuticals USD 1.21B 125.6M 2024-12



Neurocrine Biosciences سهم - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.